Increased expression of YKL-40, a chitinase-like protein, in serum and lung of patients with idiopathic pulmonary fibrosis

Respiratory Medicine

Volumn 104, Issue 8, 2010, Pages 1204-1210

  Furuhashi, Kazuki ^a   Suda, Takafumi ^a   Nakamura, Yutaro ^a   Inui, Naoki ^a   Hashimoto, Dai ^a   Miwa, Seiichi ^b   Hayakawa, Hiroshi ^b   Kusagaya, Hideki ^c   Nakano, Yutaka ^c   Nakamura, Hirotoshi ^a   Chida, Kingo ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b National Hospital Organization   (Japan)

^c SEIREI MIKATAHARA GENERAL HOSPITAL   (Japan)

Author keywords

Chitinase like proteins; Idiopathic pulmonary fibrosis; YKL 40

Indexed keywords

CHITINASE; PROTEIN YKL 40; UNCLASSIFIED DRUG;

AGED; ARTICLE; BRONCHUS MUCOSA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROSING ALVEOLITIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

AGED; BRONCHOALVEOLAR LAVAGE FLUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOPROTEINS; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; IMMUNOHISTOCHEMISTRY; LECTINS; MALE; RESPIRATORY FUNCTION TESTS;

EID: 77953916068     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2010.02.026     Document Type: Article

References (26)

1. Katzenstein A.L., and Myers J.L. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 157 (1998) 1301-1315
2. Selman M., King T.E., and Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 134 (2001) 136-151
3. Kelly M., Kolb M., Bonniaud P., and Gauldie J. A re-evaluation of fibrogenic cytokines in lung fibrosis. Curr Pharm Des 9 (2003) 39-49
4. Hakala B.E., White C., and Recklie A.D. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 268 (1993) 25803-25810
5. Boot R.G., Blommaart E.F., Swart E., et al. Identification of a novel acidic mammalian chitinase distinct from chitotriosidase. J Biol Chem 276 (2001) 6770-6778
6. Johansen J.S., Christoffersen P., Møller S., et al. Serum YKL-40 is increased in patients with hepatic fibrosis. J Hepatol 32 (2000) 911-920
7. De Ceuninck F., Gaufillier S., Bonnaud A., Sabatini M., Lesur C., and Patoureau P. YKL-40 (Cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes. Biochem Biophys Res Commun 285 (2001) 926-931
8. Recklies A.D., White C., and Ling H. The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular single-regulated kinase- and protein kinase B-mediated signaling pathways. Biochem J 365 (2002) 119-126
9. Malinda K.M., Ponce L., Kleinman H.K., Shackelton L.M., and Millis A.J. Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells. Exp Cell Res 250 (1999) 168-173
10. Chupp G.L., Lee C.G., Jarjour N., et al. A chitinase-like protein in the lung and circulation of patients with severe asthma. N Engl J Med 357 (2007) 2016-2027
11. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement: American Thoracic Society and the European Respiratory Society. Am J Respir Crit Care Med 161 (2000) 646-664
12. Suda T., Chida K., Hayakawa H., et al. Development of bronchus-associated lymphoid tissue in chronic hypersensitivity pneumonitis. Chest 115 (1999) 357-363
13. Volck B., Johansen J.S., Stoltenberg M., et al. Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology. Osteoarthr Cartil 9 (2001) 203-214
14. Baeten D., Boots A.M., Steenbakkers P.G., et al. Human cartilage gp-39+, CD16+ monocytes in peripheral blood and synovium: correlation with joint destruction in rheumatoid arthritis. Arthritis Rheum 43 (2000) 1233-1243
15. Rathcke C.N., and Vestergaard H. YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis. Inflamm Res 55 (2006) 221-227
16. Bigg H.F., Wait R., Rowan A.D., and Cawston T.E. The mammalian chitinase-like lectin, YKL-40, binds specifically to type I collagen and modulates the rate of type I collagen fibril formation. J Biol Chem 281 (2006) 21082-21089
17. Kamal S.M., Turner B., He Q., et al. Progression of fibrosis in hepatitis C with and without schistosomiasis: correlation with serum markers of fibrosis. Hepatology 43 (2006) 771-779
18. Nøjgaard C., Johansen J.S., Christensen E., et al. Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease. J Hepatol 39 (2003) 179-186
19. Johansen J.S., Stoltenberg M., Hansen M., et al. Serum YKL-40 concentrations in patients with rheumatoid arthritis: relation to disease activity. Rheumatology 38 (1999) 618-626
20. Johansen J.S., Milman N., Hansen M., Garbarsch C., Price P.A., and Graudal N. Increased serum YKL-40 in patients with pulmonary sarcoidosis - a potential marker of disease activity?. Respir Med 99 (2005) 396-402
21. Kruit A., Grutters J.C., Ruven H.J., Moorsel C.C., and van den Bosch J.M. A CHI3L1 gene polymorphism is associated with serum levels of YKL-40, a novel sarcoidosis marker. Respir Med 101 (2007) 1563-1571
22. Nordenbaek C., Johansen J.S., Halberg P., et al. High serum levels of YKL-40 in patients with systemic sclerosis are associated with pulmonary involvement. Scand J Rheumatol 34 (2005) 293-297
23. Létuvé S., Kozhich A., Arouche N., et al. YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages. J Immunol 181 (2008) 5167-5173
24. Martinez F.J., and Flaherty K. Pulmonary function testing in idiopathic interstitial pneumonias. Proc Am Thorac Soc 3 (2006) 315-321
25. Sun A.P., Ohtsuki Y., Fujita J., Ishida T., Yoshinouchi T., and Kohno N. KL-6, a human MUC1 mucin, is expressed early in premature lung. Respir Med 97 (2003) 964-969
26. Ohnishi H., Yokoyama A., Kondo K., et al. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am J Respir Crit Care Med 165 (2002) 378-381